Systemic lupus erythematosus (SLE), an autoimmune disease characterised by anti-nuclear autoantibodies and a type I interferon (IFN) signature, displays one of the most striking female-biased imbalances (9:1) in disease prevalence. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.